Henk‐Jan Guchelaar

The Risk of Cancer in Users of Statins

Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts et al. · Journal of Clinical Oncology · 2004 · 523 citations

Standardizing <i><scp>CYP</scp>2D6</i> Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Kelly E. Caudle, Katrin Sangkuhl, Michelle Whirl‐Carrillo et al. · Clinical and Translational Science · 2019 · 496 citations · Full text

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 403 citations · Full text

Medicine, Prospective Safety Analysis, Cancer Management +9

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and Tamoxifen Therapy

Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar et al. · Clinical Pharmacology & Therapeutics · 2018 · 311 citations · Full text